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Ion Channels: Too Complex Meeting Review
for Rational Drug Design?
Steve A. N. Goldstein* and Thomas J. Colatsky² channel KIR6.2 (Sakura et al., 1995). SUR1 also interacts
with at least three other inward rectifiers (KIR6.1, KIR1.1,*Department of Pediatrics
and a channel endogenous to HEK293 cells), endowingDepartment of Cellular and Molecular Physiology
them with sensitivity to inhibition by sulfonylureas (AÈ m-Boyer Center for Molecular Medicine
maÈ laÈ et al., 1996).Yale University School of Medicine
Joseph Bryan (Baylor University) argued as well thatNew Haven, Connecticut 06536-0812
KATP channels in pancreatic b cells are aggregates of² Ion Channel Research Group
SUR1 and KIR6.2 subunits (Inagaki et al., 1995). He of-Division of Cardiovascular and Metabolic Diseases
fered evidence that these two proteins physically asso-Wyeth±Ayerst Research
ciate and suggested that complete KATP channels mightPrinceton, New Jersey 08543-8000
form as octomers containing four of each subunit type.
Bryan next reported on identification (with Alan Perl-
mutt's group, Washington University) of a new mutationIntroduction
in SUR1 that causes persistent hyperinsulinemic hypo-
glycemia of infancy (PHHI), an autosomal recessive dis-Beneath soaring eagles and snow-capped peaks, a Key-
order characterized by unregulated insulin secretion.stone Symposium was held from February 4±10, 1996,
Unlike two previously recognized mutations that resultin Tamarron, Colorado. Under the banner, ªIon Channels
in aberrant SUR1 mRNA processing and truncate theas Therapeutic Targets,º the organizers (Michael Caha-
second nucleotide binding fold (Thomas et al., 1995),lan, University of California, Irvine; K. George Chandy,
the new mutation (G1479R) generates channels that areUniversity of California, Irvine; Doug Hanson, Pfizer; Alan
normally inhibited by ATP but are not activated byNorth, Glaxo Institute) brought together scientists from
MgADP. Bryan suggested that the second nucleotide-academia and industry and dared us to admit to our
binding fold is the site mediating MgADP activation and,successes and failures. At the heart of this challenge
thus, that SUR1 acts as the nucleotide sensor of KATPwas a question: can drugs acting on ion channels be
channels and ADP as the key physiological regulator inrationally designed? The driving motivation behind mo-
b cells (Nichols et al., 1996).lecular-based drug design is clear: all drugs now mar-
Both Bryan (with S. Seino, Chiba University) and
keted that act on ion channels were discovered empiri-
Charles Burant (University of Chicago) reported cloning
cally (either by clinical use for other indications or by
a new member of the SUR family. SUR2 has a wider
broad functional screening) rather than by molecular
tissue distribution than SUR1 including heart, adipo-
insight, and most have been shown to have serious
cytes, bladder, skeletal muscle, and vascular smooth
safety and efficacy problems. Granted, our new scien-
muscle but not neuronal tissue in the brain. Bryan re-
tific methods are implicating ion channel dysfunction in
vealed that SUR2±KIR6.2 channels are 10-fold less sensi-some disease states and identifying new drug targets
tive to ATP and glibenclamide than SUR1 channels and
as well as new modes of drug action, but are we moving
are completely insensitive to diazoxide (Inagaki et al.,
toward development of more successful ion channel
1996 [this issue of Neuron]). He further showed that
modulating drugs? Here, we review the symposium pre-
SUR2 exhibits greater specificity in subunit association:
sentations partitioned into three catagories: known tar- it couples only with KIR6.2 and not KIR6.1.gets and drugs in use, new targets and drug candidates, Gary Grover (Bristol±Myers Squibb) reviewed his
and new biology. The efforts of the organizers were group's experience with agents that act to open myocar-
rewarded with at least two tangible results: first, a foun- dial KATP channels as cardioprotectants. While the mo-
dation was laid for deÂ tente between accrued knowledge lecular identity of the cardiacKATP channel remains unde-
using older methods and newly emerging opportunities; fined, the current is prominent in cardiac ventricular
second, the slopes remained barren and lecture hall full. tissue. One lead compound under study (BMS 180448)
reduces infarct size in selected animal models and ap-
Known Targets and Drugs in Use pears to act via diazoxide-sensitive channels in cardiac
Sulfonylurea Receptors, ATP-Sensitive K1 mitochondria rather than on sarcolemmal KATP channels.
Channels, the Pancreas, and Beyond Heart Rate, IKACh, and GIRK/CIR K1 Channels
Sulfonylureas are a class of drugs used to treat non- David Clapham (Mayo Clinic and Research Foundation)
insulin-dependent diabetes mellitus. They act by bind- described his group's identification of the molecular
ing to sulfonylurea receptors (SURs), members of the components that mediate slowing of the heartbeat when
ABC transporter family that are present on pancreatic acetylcholine (ACh) is secreted by the vagus nerve. He
b cells. Drug binding inhibits ATP-sensitive K1 channels presented compelling evidence that ACh binding to
(KATP), and this leads to insulin secretion. Whether SURs atrial muscarinic receptors leads to IKACh current activa-
and KATP channels are separate molecular entities has tion in a G protein bg subunit±dependent process. Clap-
been a subject of intense debate. Frances Ashcroft (Ox- ham revealed that the channel underlying IKACh is a heter-
ford University) presented her group's recent work omultimer of two distinct inwardly rectifying K1 channel
showing that SUR1 does not possess intrinsic channel subunits, GIRK1 (KIR1.1) and a newly cloned member of
activity and that functional b cell KATP channels are, in the family, CIR, which is found in the heart exclusively
in the atria (KIR3.4; Krapivinsky et al., 1995). He showedfact, a complex of SUR1 and the inwardly rectifying K1
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biochemical evidence for direct binding of Gbg (but not was offered to explain Ca21 effects on DHP±channel
Ga) to recombinant GIRK1/CIR channel subunits as well interaction: a single Ca21 ion within the channel may
as to native IKACh channels immunoprecipitated from car- increase the apparent affinity of DHP antagonists, while
diac tissue. These findings resolve confusion regarding two Ca21 ions in the channel (representing the conduct-
three key issues. First, Gbg binds to and activates IKACh. ing state) makes drug binding energetically unfavorable
Second, CIR is not a component of the cardiac KATP (Peterson and Catterall, 1995).
channel; as noted above, the molecular identity of this David Triggle (State University of New York at Buffalo)
channel is not yet known, although it seems likely to be discussed the widespread use of L-type Ca21 channel
a SUR±inward rectifier complex. Third, reflecting the blockers (such as nifedipine, verapamil, and diltiazem)
heteromeric nature of the native channel in atrium, in the treatment of hypertension, angina, cardiac ar-
GIRK1 does not form fully functional channels unless rhythmias, and peripheral vascular disease. The rele-
coassembled with CIR or a CIR homolog, such as XIR, vance of such consideration is revealed by a recent
which is present in uninjected Xenopus laevis oocytes meta-analysis of clinical trials showing excess mortality
(Hedin et al., 1996). in patients with acute myocardial infarction who re-
Long QT Syndrome, IKr , and HERG ceived ªshort-actingº Ca21 entry blockers like nifedipine
Michael Sanguinetti (University of Utah) first discussed (Furberg et al., 1995). Triggle's group is evaluating sec-
his group's work on drugs that block IKr, the fast delayed ond generation DHPs now entering clinical use as well
rectifier current essential to the repolarization of the as new synthetic ligands. They find significant variation
myocardium to end each heartbeat. Pharmacologic in activity, state dependence, and pharmacokinetics
block of IKr by class III antiarrhythmic drugs can delay among theagents and suggest that differences invascu-
repolarization and induce an acquired form of long QT lar selectivity of Ca21 channel antagonists, especially
syndrome (LQTS). This predisposes the heart to an un- the 1,4-DHPs, primarily reflects the effects of chemical
usual ventricular arrhythmia called torsade de pointes, structure on voltage-dependent binding (Sun and Trig-
which can degenerate into ventricular fibrillation and gle, 1995).
cause sudden death. Sanguinetti also discussed a con-
genital form of LQTS associated with mutations in
HERG, the gene that appears to encode the human New Targets and Drug Candidates
IKr channel. Analysis of the functional consequences of Voltage-Gated K1 Channels
HERG mutations reveals they cause decreased channel and the Immune System
function, similar to the effect of drug blockade (San- Kv1.3 is a voltage-gated K1 channel that has been tar-
guinetti et al., 1995). Like the drug-induced arrhythmia, geted for development of new immunosuppressive
the congenital syndrome is characterized by torsade agents that might have fewer toxic side effects than
de pointes and can lead to sudden death. Sanguinetti currently prescribed drugs. Activity of this channel is an
reported that HERG (like IKr in myocytes) is activated by obligatory step in T cell proliferation. Blockers of Kv1.3
extracellular K1 and that elevation of serum K1 by z1.3 are expected to display selective action because ex-
mEq/L in patients with HERG mutations is sufficient
pression of the channel in peripheral tissues is highly
to normalize QT interval. Notably, among the over 20
restricted and T cells are the only cells for which Kv1.3
mutations of the HERG gene found in humans thus far,
appears to dominate control of the membrane potential.
those that diminish channel function most dramatically
Doug Hanson (Pfizer) discussed his group's results from
(for example, G628S) were isolated from patients with
a high throughput screen employing a rubidium effluxthe most severe clinical symptoms. Three other genetic
assay and cells stably overexpressing Kv1.3. A piperi-forms of LQTS have been identified involving mutations
dine lead compound was discovered that displayedin other Na1 and K1 channels in the heart (LQTS, 1996).
marked selectivity for Kv1.3 over other homologous K1Na1 and Ca21 Channels of the Heart and Nervous
channels. Studies with Kv1.3 mutants suggested thatSystem and Channel-Blocking Drugs
the observed selectivity was due to interactions be-William Catterall (University of Washington) discussed
tween the benzhydryl moiety of the blocker and His-404his group's identification of residues in Na1 and Ca21
in the Kv1.3 outer pore. However, extensive syntheticchannels that are critical for channel blockade by local
chemistry efforts failed to increase the potency and se-anesthetics and antiarrhythmics (drugs used widely for
lectivity of this class of compounds to levels suitablepain reduction and treatment of abnormal patterns of
for further development. Efforts are currently underwaycardiac electrical activity). Highlighted were point muta-
to identify new chemical leads by screening a naturaltions in the S6 segment of the fourth internal repeat
products library and also by pursuing a structural-basedof the pore-forming a subunit of each channel. In Na1
approach in collaboration with K. George Chandy'schannels, mutations in this region reduced block by
group.lidocaine over 30-fold, altered its use dependency, and
Chandy (University of California, Irvine) described hiscreated a new access pathway that permitted rapid
group's recent success in detailing the unknown con-blocker dissociation. Ca21 channel mutations in similar
tours of the outer pore vestibule of Kv1.3 using peptidelocations dramatically decreased block by the phenylal-
neurotoxins of knownthree-dimensional structure (Aiyarkylamine (2)D888 (Ragsdale et al., 1994; Hockerman et
et al., 1995). The toxins bind in the mouth of the channelal., 1995). That these same amino acid residues were
with picomolar affinity and block conduction by formingless important in Na1 channels for block by quinidine
a 1:1 complex. One goal of this mapping is to identifyor phenytoin, and a distinct site in Ca21 channels is
structural attributes that make the Kv1.3 pore unique.responsible for block by dihydropyridines (DHPs), sug-
gests a basis for specificity among the drugs. A model This provides a first step toward design of compounds
Meeting Review
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that will bind to Kv1.3 with high affinity, because they Alan Mueller (NPS Pharmaceuticals) discussed his
group's work with Araxin compounds, so named be-are structurally complementary, but will interact poorly
with the scores of related K1 channels in the body. A cause the lead agents were isolated from arachnid (spi-
der) toxins. These compounds are noncompetitive glu-histidine residue in the pore appears to provide such
a singular target. James Rizzi (Amgen) presented an tamate antagonists; they appear to act as open channel
blockers and have pharmacological profiles that areoverview of how computer aided design was applied
to the design of new Kv1.3 inhibitors. The approach unique. Araxin compounds have been used in rodent
models and are effective as anticonvulsants, as neuro-combines information gleaned from studying toxin±
channel interactions as well as the interaction of small protectants in models of ischemic stroke, and as analge-
sics with potency similar to morphine. NPS is pursuingmolecules with the channel. No candidate compound
with marked efficacy has yet surfaced in the early phase the development of a clinical candidate selected from
a series of small synthetic molecules (z250 kDa) thatof the project.
H. Robert Guy (National Institutes of Health) used data are readily produced and appear to be more potent than
the original Araxin compounds.generated by Chandy's group, as well as others studying
toxin±K1 channel interactions and the behavior of chan-
nel point mutants, to elaborate an updated short pore
New Biologymodel of Shaker-type K1 channels. Guy also offered a
New Channelsnew proposal for arrangement of transmembrane heli-
Peter Agre (Johns Hopkins University) discussed theces in the channels incorporating recent information
function and structure of aquaporin (AQP) water chan-on the role of the second and fourth transmembrane
nels. This family of channels plays a fundamental rolesegments in voltage gating (Papazian et al., 1995; Yang
in transmembrane water movement and enjoys wideet al., 1996; Larsson et al., 1996). Such models have
tissue distribution in humans (AQP-1 is in the kidney,enjoyed notable success in the past (Guy and Seethara-
eye, and capillary endothelium; AQP-2 and AQP-3 aremulu, 1986). They provide direction for mechanistic ex-
in the kidney with the former sorted to apical and theperimentation and have contributed to recent enthusi-
latter to basolateral membranes; AQP-4 is in the brainasm for rational design of drugs acting on ion channels.
in astroglial cells; AQP-5 is in the lungs). Agre indicatedCa21-Activated K1 Channels in Vascular
that insertion and turnover of AQP-2 in renal collectingand Respiratory Smooth Muscle and in the Brain
duct membranes is regulated by vasopressin and thatThe Ca21-activated K1 (CaK) channel family is widely
mutations in AQP-2 can cause a severe form of nephro-expressed, and compounds that modulate members of
genic diabetes insipidus. His group employed electronthis family are expected to have utility in the treatment
crystallography and site-directed mutagenesis to revealof stroke, epilepsy, hypertension, and asthma. Maria
the tetrameric organization of AQP-1 and its unique ob-Garcia (Merck) discussed her group's isolation and char-
verse internal symmetry (Walz et al., 1995).acterization of the two subunits (a and b) that assemble
Alok Mitra (Scripps Research Institute) took the audi-to form these channels in aortic and tracheal smooth
ence through theprocess of performing electron crystal-muscle. The a subunits are pore forming and can func-
lography using frozen-hydrated two-dimensional crys-tion alone; however, the b subunits are tightlyassociated
tals of AQP-1 from human erythrocytes (Mitra et al.,in native tissue and increase the sensitivity of the chan-
1995). He showed that each AQP-1 monomer has anel to calcium over 10-fold: this leads to a shift in the
separate vestibule leading to a water-filled cavity en-voltage sensitivity of channel of over 80 mV (Knaus et
closed by multiple transmembrane a helices.al., 1994). Using a high throughput assay to identify
Richard Lewis (Stanford University) discussed hiscompounds that interfere with binding of radiolabeled
group's work on the function of Ca21 release±activatedcharybdotoxin, two lead compounds have been identi-
Ca21 (CRAC) channels present in T cells. Through studyfied, one (a glycosylated triterpene) that favors channel
of mutant T cell lines, they revealedCRAC channels tobeopening and another (an indole diterpene) that blocks
the only Ca21 influx pathway activated by T cell antigenthe channel. Immunolocalization reveals the presence
receptors. Moreover, this Ca21 influx was found to beof CaK channels in neurons with a notable predilection
essential for triggering the genes associated with im-for presynaptic nerve terminals in rat brain sections.
mune activation, such as interleukin-2 (IL-2). ModulatorsCa21 Channels and Toxins from Snails
of CRAC channels thus offer a new target for immuno-and Spiders
suppressive therapy. Lewis indicated that depletion ofGeorge Miljanich (Neurex) discussed the emerging pro-
internal Ca21 stores acts to open CRAC channels, whilefile of the snail peptide SNX-111 (a conopeptide) as a
increased intracellular Ca21 levels inhibits their activity.neuroprotectant in head trauma and in the treatment
This leads to oscillations in internal T cell Ca21 levels.of intractable pain. The compound blocks N-type Ca21
Oscillations were most prominent at low levels of anti-channels (which are widely distributed in the brain and
gen stimulation and, surprisingly, were more potent thanhighly localized to the outer layers of the dorsal horn
matched constant elevations of Ca21 for inducing ex-of the spinal cord). In a preclinical study, the peptide
pression of IL-2 reporter constructs (Zweifach andappeared to block apoptosis and reduce cerebral infarct
Lewis, 1995).size in animal models. In phase I/II clinical studies, the
Alan North (Glaxo Institute) described his group's re-agent was administered intrathecally to 10 patients with
cent work on P2X receptors, the cation-selective ionterminal cancer and intractable pain; a clear benefit was
channels that open on binding of extracellular ATP.demonstrated with no adverse effects, and the study
has been expanded to about 30 patients. mRNA for P2X channels is found widely through the
Neuron
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brain and spinal cord where the channels appear to play combinations have been established for evaluation us-
ing an automated Ca21 fluorescence-based screen witha role in fast synaptic transmission between neurons
a capacity of >600 assays each hour.and in communication between autonomic nerves and
RNA Editing, Glutamate Receptor Channels,smooth muscles. P2X mRNA is also expressed in T cells
and the Central Nervous Systemand pituitary gland tissue, suggesting a possible role
Glutamate receptors (GluRs) are ligand-gated channelsfor these channels in immune and endocrine function
that conduct Ca21 and monovalent cations. These chan-(Lewis et al., 1995). The six members of the family cloned
nels mediate fast excitatory neurotransmission in thethus far are 36%±48% identical and show no relation to
central nervous system of humans and are speculatedother ligand-gated ion channels. The six clones show
to play an important role in learning as molecular coinci-differences in tissue distribution as well as diversity in
dence detectors. GluRs exhibit wide molecular diversitygating, agonist sensitivity, and blocker sensitivity. They
as a result of multiple GluR genes, alternative transcriptall appear to have two membrane-spanning segments
splicing, and combinatorial variation. Steve Heinemannwith a large extracellular loop.
(Salk Institute) and Peter Seeburg (ZMBH, Heidelberg)Bernard Rossier (UniversiteÂ de Lausanne) discussed
discussed their groups' efforts to understand the basisamiloride-sensitive epithelial Na1 channels (ENaCs).
of yet another type of GluR diversity. The Ca21 perme-These channels are critical for water and salt homeosta-
ability and rectifying properties of these channels aresis and are expressed in the kidney, colon, and lung.
subject to regulation by a change in the amino acidENaCs assemble as heteromultimers of three homolo-
present at a unique channel position (Hume et al., 1991).gous subunits (a, b, and g) with unknown stoichiometry.
Underlying this change isan RNA editing process involv-Mutations that result in increased ENaC activity lead to
ing deamination of adenosine to inosine that was firsthypertension. Liddle's syndrome is an autosomal domi-
elucidated in two kainate-sensitive GluR subunits (Som-nant disease characterized by early onset hypertension
mer et al., 1991). Thus, while thegene for GluR2 encodesdue to constitutive ENaC activity and salt accumulation;
a glutamine (CAG) at this position, editing yields a pro-two mutations that cause the syndrome truncate of the
tein with an arginine (CI/GG) at the site. RNA editing isC-terminal region of the b (Schild etal., 1995) or g subunit
a nuclear process that targets specific adenosines and(Hansson et al., 1995). Conversely, mutations that de-
requires a double-stranded RNA structure configuredcrease ENaC activity appear to lead to salt wasting and
from complementary exonic and intronic sequences (Hi-respiratory distress. Thus, homozygous transgenic mice
guchi et al., 1993). The editing mechanism is specificÐin which ENaC genes have been knocked out developed
only GluR2 RNA is edited in a glial cell line even thoughacute respiratory distress and cyanosis postpartum. The
GluR1, GluR3, GluR4, and GluR6have similar sequencesanimals died within 48 hr of birth due to excess fluid in
at the siteÐand depends on an intronic sequence in thethe lungs; this suggests a critical role for ENaCs in nor-
GluR2 gene that is sufficient to cause editing of GluR3mal fluid clearance from the lungs.
in a chimeric construct (Egebjerg et al., 1994). The occur-Channel Diversity
rence of inosine in othermammalian mRNAs is expectedJohn Adelman (Vollum Institute), whose earlier studies
since HeLa cell extracts can edit GluR pre-mRNA withhighlighted the wide variety of CaK channels (over 100)
positional accuracy (Melcher et al., 1995).that results from alternative splicing (Lagrutta et al.,
Heinemann also discussed the role of the extracellular1994), offered yet another dimension to the structural
S2 channel segment in ligand affinity showing that itcomplexity of this channel family. Using a variant of the
determines the kainate affinity of GluR chimeras intoyeast two-hybrid system, his laboratory has identified
which it is grafted (Stern-Bach et al., 1994). Seeburg'ssix new genes whose protein products associate with
group found that the C-terminal cytoplasmic domain of
theC-terminal domain of a Drosophila CaK channel. One
N-methyl-D-aspartate (NMDA) receptors could interact
clone appears to yield a soluble protein, is expressed
with postsynaptic densityprotein PSD-95 in a yeast two-
in the developing nervous system of flies, and acts to
hybrid assay. This is consistent with their observation
diminish CaK currents when coexpressed in Xenopus of similar expression patterns for PSD-95 and NMDA
oocytes. The effect is specifically reversed when the receptor transcripts in rat brain as well as their colocali-
C-terminal portion of CaK is also expressed, suggesting zation in cultured rat hippocampal neurons. Seeburg
the new clone is an additional modulatory subunit of suggested that interaction of these proteins may affect
CaK channels. the plasticity of excitatory synapses (Kornau etal., 1995).
Michael Harpold (SIBIA) discussed his group's efforts Channel Structure and Function
to screen for subtype-selective modulators of neuronal Richard Aldrich (Stanford University) offered data to
Ca21 channels. He revealed this goal to be complicated support the novel proposition that inward rectification
by the existence of wide combinatorial diversity in Ca21 and outward rectification in K1 channels can result solely
channel subtypes. These channels are composed of from a shift in the voltage dependence of channel activa-
three distinct subunits (a1, a2d, and b). At least five genes tion. Thus, wild-type Shaker channels pass outward K1
encoding different pore-forming a1 subunits and four currents when the membrane is depolarized from a neg-
genes encoding different b subunits have thus far been ative resting potential of 280 mV to 0 mV; the channels
identified in the nervous system. Moreover, splice vari- undergo a conformational change from resting to open
ants of a1 and b subunits have been identified that form state with a midpoint for activation of 240 mV. If the
channels with unique gating and conduction attributes membrane remains depolarized (0 mV), channels rapidly
when coexpressed with a neuron-specific a2d subunit. move to a nonconducting inactivated state that results
from block of the open channel by its cytoplasmicBravely, cell lines expressing various human subunit
Meeting Review
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N-terminus. On the other hand, Shaker channels whose These Ca21 ªsparksº (so-called because of their appear-
ance when visualized with Ca21 sensitive dyes) weremidpoint for activation is shifted below 2200 mV by
point mutation are chronically inactivated at a resting observed just under the surface membrane of single
smooth muscle cells from myogenic cerebral arteries.potential of 280 mV. These channels show no outward
currents on depolarization (they are already opened and Ca21 sparks appear to result from opening of only 1 or
2 channels that, in turn, activate 20±100 CaK channelsinactivated) but show inward currents on further hyper-
polarization as they recover from inactivation and move leading to cellular hyperpolarization and arterial dilation.
These effects on membrane permeability were manifestthrough the open channel state on the way to the resting
closed state (Miller and Aldrich, 1996). electrophysiologically as spontaneous transient out-
ward currents (STOCs). Ca21 sparks have little effectKevin Campbell (University of Iowa) reported his
group's examination of the molecular basis for subunit on spatially averaged Ca21 levels that regulate arterial
contraction (Nelson et al., 1995).interactions in voltage-gated Ca21 channels using a di-
rect binding assay. Mutations in the a1 subunit that ab- Michael Cahalan (University of California, Irvine) dis-
cussed the emerging roles of K1 and Ca21 channels inlate binding to an in vitro translated b subunit suggest
that the a1±b interaction involves the cytoplasmic loop lymphocyte function (Negulescu et al., 1994; Lewis and
Cahalan, 1995). T cell activation begins with stimulationbetween homologous domain I and II of the a1 compo-
nent. The a1 subunit was found to interact with various of T cell antigen receptors, activation of Kv1.3 K1 chan-
nels, and influx of Ca21 through CRAC channels. (Theb subtypes from native tissues and a single tyrosine
residue in a1 was found to be critical for this interaction K1 channels support a negative membrane potential
that drives Ca21 influx.) Within seconds, a sustained rise(Witcheret al., 1995; De Waard et al., 1995). Interestingly,
the d subunit is critical for the a1±a2d interaction and the in intracellular Ca21 levels occurs leading to IL-2 gene
expression; this cytokine is essential for T cell prolifera-eighteen potential glycosylation sites in the a2d subunit
appear to stabilize the interaction (Gurnett et al., 1996). tion and immune response. As noted above, blockade of
Kv1.3 inhibits antigen-driven activation of lymphocytes,Steve Goldstein (Yale University) discussed his
group's studies of minK, a protein with just 130 amino probably by diminishing Ca21 oscillations that result
from activation of plasma membrane CRAC channels.acids that is found in cardiac, renal, uterine, auditory,
and gastrointestinal tissue. MinK bears no homology to Using video-imaging techniques, Cahalan's group
tracked Ca21 signals in individual T cells and measuredknown channels, but its expression in Xenopus oocytes
yields K1 currents remarkably similar to those underly- expression of a reporter gene controlled by the NF-AT
element of the IL-2 enhancer. Raising Ca21 from restinging cardiac repolarization and found in auditory epithe-
lia. Goldstein presented data supporting the direct con- levels increased the fraction of cells showing gene ex-
pression and decreased mobility of the cells (presum-tribution of minK residues to the lining of a K1 channel
pore. He argued that functional channel complexes con- ably this fosters T cell accumulation at sites of stimula-
tory antigen). Ca21-dependent IL-2 gene expression wastain just two minK monomers and that an as yet uniden-
tifed non-minK protein appears to be required for chan- enhanced by activation of protein kinase C but inhibited
by stimulation of protein kinase A.nel function and may contribute to the pore as well
(Wang and Goldstein, 1995; Wang et al., 1996). Iain Dukes (Glaxo Institute) presented his group's ef-
forts to understand themolecular basis for glucose stim-Steve Siegelbaum (Columbia University) offered new
evidence about the structural basis for opening of cyclic ulated secretion of insulin by b cells of the pancreas
(Worley et al., 1994; Philipson et al., 1994). Insulin secre-nucleotide±gated (CNG) cation channels from retinal
and olfactory epithelia, building on his group's previous tion is associated with b cell membrane depolarization
and elevation of intracellular Ca21 levels. Dukes showedprogress (Goulding et al., 1994). He showed that activa-
tion of these channels is determined by two channel that depleting intracellular Ca21 stores induced mem-
brane depolarization and led to a sustained Ca21 influx;domains: first, a 25 residue domain in the C-terminal
region that participates in ligand binding and thus deter- on the other hand, interventions promoting Ca21 store
refilling produced hyperpolarization and inhibited Ca21mines selectivity between cAMP and cGMP (this region
is homologous to the C-helix in the Escherichia coli influx. These results suggest a role for nonselective cat-
ion channels that are stimulated by depletion of intracel-protein CAP). The second domain is a large N-terminal
region that determines differences in gating between lular Ca21 stores. They examined the role of voltage-
gated K1 channels in insulin secretion by producing achannel isoforms. To understand how this non-ligand-
binding domain of thechannel might exert this influence, transgenic mouse strain that overexpresses an insu-
linoma-derived K1 channel in its pancreatic b cells.they studied spontaneous openings of channel chime-
ras. Siegelbaum argued convincingly for an allosteric Whole-cell recordings confirmed expression of the
channels in transgenic islet cells; expression was corre-model in which the N-terminal domain of the protein
influences channel open probability because it deter- lated with hyperglycemia and hypoinsulinemia and sup-
ports a role for K1 channels in excitation±secretion cou-mines the free energy difference between closed and
open states of the channel in the absence of ligand. pling.
New MethodsCa21 Mediation of Vascular Tone, Immunity,
and Pancreatic Function Roger Tsien (University of California, San Diego) de-
scribed the advances his group has made using fluores-Mark Nelson (University of Vermont) discussed how con-
trol of cerebrovascular tone by smooth muscle involves cence resonance energy transfer to assess rapid
changes in transmembrane voltage in individual cells assmall local releases of Ca21 from sarcoplasmic reticulum
through ryanodine-sensitive Ca21-release channels. well as to study protein±protein interactions and gene
Neuron
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expression. Previously, voltage-sensing dyes were ei- combinatorial possibilities for channel assembly, and
secondary mediator pathways that had been presentedther sensitive and slow or insensitive and fast. A two
component system now allows both sensitivity and at this symposium alone. The optimists among us simply
saw the cacophony of biological, functional, and struc-speed (time constant ≈ 2 ms). The approach employs,
first, a hydrophobic fluorescent anion that moves rapidly tural complexity as new opportunity for specificity in
drug action. All conferees agreed, however, that thefrom one face of the membrane to the other in response
to voltage changes; the second fluorophore is fixed to symposium had produced an amalgamation and of old
and new ideas as well as a confederation of academicthe extracellular surface and undergoes energy transfer
with the membrane bound probe. High speed confocal and industrial scientists that heralded the maturing of
the endeavour.microscopy was achieved as was continuous monitor-
ing of beating cardiac myocytes through elimination of
movement artifact by ratiometric measurements (Gon- References
zalez and Tsien, 1995). Tsien also described a new re-
Aiyar, J., Withka, J.M., Rizzi, J.P., Singleton, D.H., Andrews, G.C.,porter gene system utilizing b-lactamase to separate
Lin, W., Boyd, J., Hanson, D., Simon, M., Dethlefs, B., Lee, C.L.,
donor from acceptor fluorophores; the method is sensi- Hall, J.E., Gutman, G.A., and Chandy, G. (1995). Topology of the
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